Hematology Highlights: News from the 50th Annual Hematology Meeting
January 24, 2009
Chicago, Illinois, United States
Westin River North
Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. Imedex, LLC designates this educational activity for a maximum 6.0 of AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is designed for hematologists/oncologists, internists, and other healthcare professionals (physician assistants, nurses, nurse practitioners, and pharmacists) with an interest and/or involvement in hematologic malignancies.
Objectives
After successful completion of this course, participants should be able to:
- Analyze emerging data on multiple hematologic malignancies and benign abnormalities toward improved patient outcomes
- Explain the limitations and benefits of new and emerging therapies for the treatment of patients with benign and malignant
- Incorporate emerging data into the clinical management of patients with benign and malignant hematologic conditions
- Discuss ways in which current clinical practice should be modified based on the latest advances in hematology
Rafat Abonour, MD
Indiana University Medical Center
Indianapolis, Indiana
James O. Armitage, MD
University of Nebraska Medical Center
Omaha, Nebraska
William I. Bensinger, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington
Morton Coleman, MD
Weill Medical College of Cornell University
New York, New York
Larry D. Cripe, MD
Indiana University
Melvin and Bren Simon Cancer Center
Indianapolis, Indiana
Asher A. Chanan-Khan, MD
Roswell Park Cancer Institute
Buffalo, New York
Myron S. Czuczman, MD
Roswell Park Cancer Institute
Buffalo, New York
Marcel P. DeVetten, MD
University of Nebraska Medical Center
Omaha, Nebraska
John F. DiPersio, MD, PhD
Washington University School of Medicine
St. Louis, Missouri
Alessandra Ferrajoli, MD
M. D. Anderson Cancer Center
Houston, Texas
Rafael Fonseca, MD
Mayo Clinic
Scottsdale, Arizona
Peter L. Greenberg, MD
Stanford Comprehensive Cancer Center
Stanford, California
Ronald Hoffman, MD
Mt. Sinai School of Medicine
New York, New York
Sagar Lonial, MD
Emory University Winship Cancer Institute
Atlanta, Georgia
Ruben A. Mesa MD
Mayo Clinic
Rochester, Minnesota
Nikhil C. Munshi, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
Stephen D. Nimer, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Owen A. O’Connor, MD, PhD
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York
Carol S. Portlock, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Jerry P. Radich, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington
Paul G. Richardson, MD
Dana-Farber Cancer Institute
New York, New York
Gail J. Roboz, MD
Weill Medical College of Cornell University
New York, New York
Seema Singhal, MD
Northwestern University
Chicago, Illinois
Steven P. Treon, MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts
** This is a draft agenda. Final topics to be selected based on abstracts released during the 2008 ASH® Meeting.
7:00 am
Breakfast and registration
8:00 am
Welcome and introduction
8:15 am
Multiple Myeloma
9:20 am
Chronic Lymphocytic Leukemia (CLL)
10:00 am
Break
10:30 am
Myelodysplastic Syndromes (MDS)
11:15 am
Chronic Myelogenous Leukemia (CML)
11:55 am
Lunch
1:15 pm
Myeloproliferative Disorders (MPD)
1:55 pm
Lymphomas
3:00 pm
Break
3:20 pm
Acute Leukemia
4:00 pm
Adjourn
![]()
Registration Fees
Physicians . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 99.00
Nurses/Residents/Students*. . . . . . . . . . . . . . . .$ 45.00
*proof of eligibility must accompany registration; cannot be combined with any other discounts
Pharmaceutical Industry. . . . . . . . . . . . . . . . . . .$175.00
To Register: You may register online up to 5 business days before the meeting atwww.imedex.com, by calling Imedex at+1 (678) 242 0906 or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.
Payment: To pre-register, registration and payment must be received no later than 5 business days before the meeting. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex, LLC. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 5 business days before the meeting.The amount of registration fees remitted, minus a $25 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 5 business days before the meeting.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
Crowne Plaza Times Square Manhattan
January 10, 2009
1605 Broadway New York, New York 10019
+1 800 243 6969 (toll-free from USA only)
Rate: $279 +13.375% tax +$2 per room
Hotel Registration deadline: December 22, 2008
Westin Chicago River North
January 24, 2009
320 North Dearborn Street Chicago, Illinois 60610
+1 800 937 8461 (toll-free from USA /Canada only)
Rate: S-$159/D-$189 + 15.4% tax; $30/night for extra person
Hotel Registration deadline: January 8, 2009
Palace Hotel
February 7, 2009
2 New Montgomery Street San Francisco, California 94105
+1 888 627 7196 (toll-free)
Rate: $229 + 14.065% tax
Hotel Registration deadline: January 14, 2009
Crowne Plaza Times Square Manhattan
February 7, 2009
1605 Broadway
New York, New York 10019
+1 800 243 6969 (toll-free from USA only)
Rate: $279 +13.375% tax +$2 per room
Hotel Registration deadline: January 6, 2009
For the convenience of attendees, a limited number of rooms have been reserved at the conference hotel along with the discounted rate and cut-off date as noted above plus tax. This rate is not guaranteed outside the conference dates. To reserve your room please contact the hotel reservations department at the phone number above. To receive the group rate, callers must identify themselves as being with the 2009 Hematology Highlights Meeting. Reservation requests received after the hotel cutoff date as noted above may not be guaranteed the group rate.
James Epstein, MD
Senior Medical Adviser
Imedex, LLC
Alpharetta, Georgia
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
|
GOLD
Millennium Pharmaceuticals, Inc.
SILVER
BRONZE
Genentech BioOncology
CORPORATE
|
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.



